{"name":"SHI Jia","slug":"shi-jia","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Prothrombin Complex Concentrate, Human","genericName":"Prothrombin Complex Concentrate, Human","slug":"prothrombin-complex-concentrate-human","indication":"Reversal of warfarin-induced anticoagulation in acute bleeding","status":"marketed"}]}],"pipeline":[{"name":"Prothrombin Complex Concentrate, Human","genericName":"Prothrombin Complex Concentrate, Human","slug":"prothrombin-complex-concentrate-human","phase":"marketed","mechanism":"Prothrombin Complex Concentrate replaces deficient vitamin K-dependent clotting factors (II, VII, IX, X) to restore coagulation cascade function and reverse anticoagulation.","indications":["Reversal of warfarin-induced anticoagulation in acute bleeding","Correction of vitamin K-dependent factor deficiency in liver disease","Management of disseminated intravascular coagulation (DIC)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFB3OUppSGxLRUNxOTFCX3JZdm14VElaTmxyQlhzNERySjVvczZuSHI0ckdPQmVPM0xqYWtVajRfN0thVk1OS3pDSWlJeFFpWnc5Q2pjZ1A3V3d2ZkFEU1RNQ003NkM2dUdkNUJmYzdfZmtXS0ZWUTVMTFp1bU9GZw?oc=5","date":"2025-11-05","type":"pipeline","source":"China Daily","summary":"Bayer eyes deeper cooperation with Chinese innovators in pharma, agriculture - China Daily","headline":"Bayer eyes deeper cooperation with Chinese innovators in pharma, agriculture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxONkNaZWwzUEhzQWh5NWFza3NZNUVsa0gwWUhWU2d3OGNNU1QxeE5mM09LN0UtblBUQUZVcERJakdhSXhaWGM3V1QyRm03ZWEwV191bUZOV3JSc1kxR0VRdDY0LVcxZ3BOQll3bWVfSTJ2c0NNR29oSkNpN3Z5WWpfUXd4R0gwRGNfeG5KaUlNMjhTZ2tUQXd5a21qVENlbWFFN1p1djFpMnkyQQ?oc=5","date":"2025-05-09","type":"pipeline","source":"Fierce Pharma","summary":"Roche pledges nearly $300M to establish new Vabysmo production plant in China - Fierce Pharma","headline":"Roche pledges nearly $300M to establish new Vabysmo production plant in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPQWhaUVhfY2tfcE5mZjJYQTRXNWJmaGdhSkc5LUdUMXNFQjZyNFJISXZXdWdTTDNSN2JQQ01kWTRZdzVpaTk3Z3Z6TWpvZ2RGczJTTnhFNVpRdG1JMV9hM2ZnTXp4MXFOclh4akZGbGtKSU9hd1NOQmZOa1RUNVJ0dkM4SHdsU1NjMjJILTJ2enk?oc=5","date":"2025-01-08","type":"pipeline","source":"ScienceDirect.com","summary":"Journal of Pharmaceutical Analysis | Vol 15, Issue 1, January 2025 - ScienceDirect.com","headline":"Journal of Pharmaceutical Analysis | Vol 15, Issue 1, January 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1FUHdqY3E5N29YbmxoSzdFUzNoSVZuaWwtTmpDdWc4U3NwRTRPYjNaMktwSF9zdEpKTmR3UlVLYXd1UnRKQWNCRnRGbFAwUEFqNlpNN29XdFB1cGtNMGdwdmpUdnlid2liT1M3amloQQ?oc=5","date":"2024-08-14","type":"pipeline","source":"Wiley Online Library","summary":"Identification of Novel Target DCTPP1 for Colorectal Cancer Therapy with the Natural Small‐Molecule Inhibitors Regulating Metabolic Reprogramming - Feng - 2024 - Angewandte Chemie International Editio","headline":"Identification of Novel Target DCTPP1 for Colorectal Cancer Therapy with the Natural Small‐Molecule Inhibitors Regulatin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBfeU1GZkcwdTM3Vk04SVhoLXRjazBYNlFHeERLRGpXaV80RUhzVFdNaDBDLUNscjhqV0FHNE1wWkdLWExxb3NhWFN4dmgyNDdLYjdqbG41MGRxcVdMSXNaNlJ3dHRMam5QYmU0b21MVQ?oc=5","date":"2024-02-27","type":"pipeline","source":"Wiley Online Library","summary":"Polycationic Open‐Shell Cyclophanes: Synthesis of Electron‐Rich Chiral Macrocycles, and Redox‐Dependent Electronic States - Shi - 2024 - Angewandte Chemie International Edition - Wiley Online Library","headline":"Polycationic Open‐Shell Cyclophanes: Synthesis of Electron‐Rich Chiral Macrocycles, and Redox‐Dependent Electronic State","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE8wbDEzbVVJUGwyUUJiakRObjAtTGowbnpTVlRPV2REejVQa0ZQX3BKUnRvMXl5MHo3cUxxTUtQdWVSRWpyeE1JTXd4MVQ4aldQb01RempwUkZ6UDV0VmtZ?oc=5","date":"2021-11-25","type":"pipeline","source":"Nature","summary":"Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine - Nature","headline":"Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFBpeWJULVVYNUhtemNYLUJEMlhmWkNHNUFlNGx0VWxNWUNBOXhLby0yUmxVY19jZVU4OG50eEZmZWtITm51RXVRMTd6ZElVVDRBZGpPbndZdm1QM1JXTUlHUWt3?oc=5","date":"2020-02-07","type":"pipeline","source":"ACS Publications","summary":"Copper-Catalyzed Oxidative Thioamination of Maleimides with Amines and Bunte Salts - ACS Publications","headline":"Copper-Catalyzed Oxidative Thioamination of Maleimides with Amines and Bunte Salts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPUmV3UUpheHpLVWdjRUJQRFk1eHYwTVZOVmJ3R2dLVnB6ZmIwUkppRFdtMndhblZpcThwR0VIb0NLaGdwY0hRMXVWZnVOeGk0dUlITTN0WXNqUVYyY0FuN0wyRTZBY3hOdGVkVGFUbEQzTl9QdlNPekFpNFFEMTdvVHYwT283VlpySV9PUnRTSQ?oc=5","date":"2019-04-22","type":"pipeline","source":"Mothership","summary":"489 NUS students sign & issue statement of concern on sexual harassment on campus - Mothership","headline":"489 NUS students sign & issue statement of concern on sexual harassment on campus","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}